127 related articles for article (PubMed ID: 34431463)
1. Targeting Triglyceride Metabolism for Colorectal Cancer Prevention and Therapy.
Yarla N; Madka V; Rao C
Curr Drug Targets; 2022; 23(6):628-635. PubMed ID: 34431463
[TBL] [Abstract][Full Text] [Related]
2. Integrated Analysis of Expression and Prognostic Values of Acyl-CoA Dehydrogenase short-chain in Colorectal Cancer.
Wu Q; Yan T; Chen Y; Chang J; Jiang Y; Zhu D; Wei Y
Int J Med Sci; 2021; 18(16):3631-3643. PubMed ID: 34790035
[No Abstract] [Full Text] [Related]
3. In vitro effects of active components of Polygonum Multiflorum Radix on enzymes involved in the lipid metabolism.
Wang W; He Y; Lin P; Li Y; Sun R; Gu W; Yu J; Zhao R
J Ethnopharmacol; 2014 May; 153(3):763-70. PubMed ID: 24680992
[TBL] [Abstract][Full Text] [Related]
4. Molecular Targets in Precision Chemoprevention of Colorectal Cancer: An Update from Pre-Clinical to Clinical Trials.
Yarla NS; Madka V; Pathuri G; Rao CV
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33348563
[TBL] [Abstract][Full Text] [Related]
5. Adipose triglyceride lipase promotes the proliferation of colorectal cancer cells via enhancing the lipolytic pathway.
Yin H; Li W; Mo L; Deng S; Lin W; Ma C; Luo Z; Luo C; Hong H
J Cell Mol Med; 2021 Apr; 25(8):3963-3975. PubMed ID: 33621408
[TBL] [Abstract][Full Text] [Related]
6. LC-MS-based lipid profile in colorectal cancer patients: TAGs are the main disturbed lipid markers of colorectal cancer progression.
Liu T; Peng F; Yu J; Tan Z; Rao T; Chen Y; Wang Y; Liu Z; Zhou H; Peng J
Anal Bioanal Chem; 2019 Aug; 411(20):5079-5088. PubMed ID: 31201454
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of type I collagen during tumorigenesis of colorectal cancer revealed by quantitative proteomic analysis.
Zou X; Feng B; Dong T; Yan G; Tan B; Shen H; Huang A; Zhang X; Zhang M; Yang P; Zheng M; Zhang Y
J Proteomics; 2013 Dec; 94():473-85. PubMed ID: 24332065
[TBL] [Abstract][Full Text] [Related]
8. Fatty Acid Metabolism-Related lncRNAs Are Potential Biomarkers for Predicting the Overall Survival of Patients With Colorectal Cancer.
Peng Y; Xu C; Wen J; Zhang Y; Wang M; Liu X; Zhao K; Wang Z; Liu Y; Zhang T
Front Oncol; 2021; 11():704038. PubMed ID: 34458145
[TBL] [Abstract][Full Text] [Related]
9. A significant role of lipogenic enzymes in colorectal cancer.
Notarnicola M; Messa C; Caruso MG
Anticancer Res; 2012 Jul; 32(7):2585-90. PubMed ID: 22753716
[TBL] [Abstract][Full Text] [Related]
10. SPARCL1 Is a Novel Prognostic Biomarker and Correlates with Tumor Microenvironment in Colorectal Cancer.
Zhang HP; Wu J; Liu ZF; Gao JW; Li SY
Biomed Res Int; 2022; 2022():1398268. PubMed ID: 35111844
[TBL] [Abstract][Full Text] [Related]
11. Molecular subtype identification and prognosis stratification by a metabolism-related gene expression signature in colorectal cancer.
Lin D; Fan W; Zhang R; Zhao E; Li P; Zhou W; Peng J; Li L
J Transl Med; 2021 Jun; 19(1):279. PubMed ID: 34193202
[TBL] [Abstract][Full Text] [Related]
12. Targeting PLA2G16, a lipid metabolism gene, by Ginsenoside Compound K to suppress the malignant progression of colorectal cancer.
Yang L; Zheng L; Xie X; Luo J; Yu J; Zhang L; Meng W; Zhou Y; Chen L; Ouyang D; Zhou H; Tan Z
J Adv Res; 2022 Feb; 36():265-276. PubMed ID: 35127176
[TBL] [Abstract][Full Text] [Related]
13. Identification of Genes Related to Clinicopathological Characteristics and Prognosis of Patients with Colorectal Cancer.
Gao X; Yang J
DNA Cell Biol; 2020 Apr; 39(4):690-699. PubMed ID: 32027181
[TBL] [Abstract][Full Text] [Related]
14. Lipidome in colorectal cancer.
Yan G; Li L; Zhu B; Li Y
Oncotarget; 2016 May; 7(22):33429-39. PubMed ID: 26967051
[TBL] [Abstract][Full Text] [Related]
15. Precision Nutrition for Targeting Lipid Metabolism in Colorectal Cancer.
Aguirre-Portolés C; Fernández LP; Ramírez de Molina A
Nutrients; 2017 Sep; 9(10):. PubMed ID: 28956850
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA profile study identifies a metabolism-related signature for colorectal cancer.
Lu Y; Wang W; Liu Z; Ma J; Zhou X; Fu W
Mol Med; 2021 Aug; 27(1):83. PubMed ID: 34344319
[TBL] [Abstract][Full Text] [Related]
17. Metabolic Pathways Regulating Colorectal Cancer: A Potential Therapeutic Approach.
Zafari N; Velayati M; Damavandi S; Pourali G; Mobarhan MG; Nassiri M; Hassanian SM; Khazaei M; Ferns GA; Avan A
Curr Pharm Des; 2022; 28(36):2995-3009. PubMed ID: 36154599
[TBL] [Abstract][Full Text] [Related]
18. Integrated Profiling Identifies
Shi J; Bao M; Wang W; Wu X; Li Y; Zhao C; Liu W
Front Immunol; 2021; 12():722807. PubMed ID: 34646265
[TBL] [Abstract][Full Text] [Related]
19. Changes in lipids composition and metabolism in colorectal cancer: a review.
Pakiet A; Kobiela J; Stepnowski P; Sledzinski T; Mika A
Lipids Health Dis; 2019 Jan; 18(1):29. PubMed ID: 30684960
[TBL] [Abstract][Full Text] [Related]
20. Identification of dysregulated lncRNAs profiling and metastasis-associated lncRNAs in colorectal cancer by genome-wide analysis.
Chen Y; Yu X; Xu Y; Shen H
Cancer Med; 2017 Oct; 6(10):2321-2330. PubMed ID: 28857495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
